Pilot and Feasibility Program

试点和可行性计划

基本信息

批准号：
10290677
负责人：
Arshiya Ahmed Baig
金额：
$ 10.64万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-09-01 至 2026-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10290677
关键词：
Area Award Biological Sciences Car Phone Chicago Collaborations Color Communities Community Health Data Development Diabetes Mellitus Discipline Dissemination and Implementation Ecology End stage renal failure Evidence based intervention Funding Funding Mechanisms Future Generations Geography Goals Grant Human Institution Intervention Investments National Institute of Diabetes and Digestive and Kidney Diseases Nature Patient Care Private Sector Publications Research Research Personnel Research Support Scientist Secure Sleep Testing Translating Translational Research Translations United States Agency for Healthcare Research and Quality United States National Institutes of Health Universities Vulnerable Populations Woman Work base care outcomes career clinical practice community organizations design engineering design ethnic minority population feasibility testing health equity improved innovation medical schools meetings novel programs racial and ethnic sedentary lifestyle success

项目摘要

PROJECT SUMMARY – Pilot and Feasibility Program The Pilot and Feasibility (P&F) grant program at the Chicago Center for Diabetes Translation Research (CCDTR) supports new areas of inquiry in diabetes translation research, with a special focus on improving the care and outcomes of vulnerable populations. The main aim of P&F program is to provide funding for investigators to explore novel hypotheses and to obtain preliminary data in order to secure long-term support from conventional funding mechanisms. Funding from the P&F program has supported new investigators who are seeking to become fully independent scientists in diabetes translation research and established investigators who are seeking to initiate diabetes-related research. Since 2011, the CCDTR P&F has received 68 applications and has awarded 41 grants, leading to 52 abstract presentations, 55 publications, and funding of 29 grants from NIDDK, NHBLI, AHRQ, and others. Grantees have received $25 million in subsequent awards with a return on investment of $28 for every $1 invested. The P&F program has made a difference for many investigators and has help establish a more diverse and collaborative network of researchers while launching the careers of several investigators in the fields of diabetes translational research. Grants have gone to 31 (76%) women, 23 (56%) investigators who identify as racial/ethnic minorities, and 19 (46%) women of color across eight institutions and 12 departments. The areas of study have included sleep interventions, care of patients with pre-end-stage kidney disease, mobile phone interventions on sedentary behavior, and human centered design approaches. Looking forward, we will amplify our reach through a novel partnership with Northwestern University (NU). This partnership will further catalyze the work that UC and NU have been conducting by providing broader reach across disciplines, institutions, and geography. Additionally, the P&F program will be furthered strengthened by expanding our scope by encouraging applications from grantees who: (1) are testing novel interventions in health equity, dissemination, and implementation; (2) bring unique perspective to diabetes research through nontraditional fields of expertise (e.g. engineering, design, environmental science); and (3) identify as URM and/or engage with stakeholders/community organizations that are URM serving and/or led. Acknowledging the importance of the P&F program, the Deans of the Biological Sciences Division at UC and Feinberg School of Medicine at NU will support the P&F program by providing $100K total in matching funds per year. With $150K funds per year, we will grant up to five grants of $25k per year and up to five “mini” grants of $5K to improve engagement and dissemination efforts. The success of our P&F program to date is a reflection of the interdisciplinary nature of our center and the strong research base it provides. Through a renewal of the CCDTR and collaboration with NU, the P&F program will be able to continue to provide necessary funding support to a new generation of innovative and diverse diabetes translation researchers and increase their chances of securing long-term funding in the future.

项目摘要——试点和可行性计划芝加哥糖尿病转化研究中心 (CCDTR) 的试点和可行性 (P&F) 资助计划支持糖尿病翻译研究的新领域，特别关注改善护理和 P&F 计划的主要目的是为研究人员提供资金探索新的假设并获得初步数据，以获得传统的长期支持 P&F 计划的资金支持了正在寻求的新研究人员。成为糖尿病转化研究中完全独立的科学家和已建立的研究人员自 2011 年以来，CCDTR P&F 已收到 68 份申请，并已开始开展糖尿病相关研究。获得 41 项资助，产生 52 篇摘要报告、55 篇出版物，并获得 NIDDK 的 29 项资助， NHBLI、AHRQ 和其他机构已获得 2500 万美元的后续奖励并获得了投资回报。每投资 1 美元即可获得 28 美元，P&F 计划为许多调查人员带来了改变并提供了帮助。建立一个更加多样化和协作的研究人员网络，同时启动一些人的职业生涯糖尿病转化研究领域的研究人员已向 31 名 (76%) 女性提供资助，其中 23 名 (56%) 八个机构中认定为少数族裔/族裔的调查员和 19 名有色人种女性 (46%) 12个科室的研究领域包括睡眠干预、晚期肾病患者的护理。疾病、手机对久坐行为的干预以及以人为本的设计方法。展望未来，我们将通过与西北大学 (NU) 建立新型合作伙伴关系来扩大我们的影响力。合作伙伴关系将通过提供更广泛的影响范围来进一步促进加州大学和NU一直在进行的工作此外，P&F 项目将进一步加强跨学科、机构和地域。通过鼓励受资助者提出申请来扩大我们的范围：(1) 正在测试新的健康干预措施 (2) 为糖尿病研究带来独特的视角非传统专业领域（例如工程、设计、环境科学）；以及 (3) 确定为 URM；和/或与 URM 服务和/或领导的利益相关者/社区组织互动。加州大学生物科学系和范伯格学院院长表示 P&F 项目的重要性 NU Medicine 将每年提供总计 10 万美元的配套资金来支持 P&F 计划。每年，我们将每年提供最多 5 笔 25,000 美元的赠款和最多 5 笔 5,000 美元的“迷你”赠款，以改善迄今为止，我们 P&F 计划的成功反映了我们的参与和传播工作。我们中心的跨学科性质及其通过更新 CCDTR 提供的强大研究基础。通过与 NU 的合作，P&F 计划将能够继续为新一代创新和多元化的糖尿病翻译研究人员，并增加他们的机会确保未来的长期资金。